News
FDA Provides Positive Feedback, Clears Path for Atossa to File IND for (Z)-Endoxifen in Metastatic Breast Cancer; FDA Indicates No Additional Toxicity Studies Required Strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback